New Delhi [India], August 27 (ANI): The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance's recombinant COVID-19 vaccine candidate.
New Delhi [India], August 9 (ANI): The Supreme Court on Monday issued notice to the Centre seeking response on disclosure of data regarding clinical trials of COVID-19 vaccines and also on post-vaccination, as the petitioner claims that it is mandatory for the Central Government to publish t
New Delhi [India], July 1 (ANI): An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sources on
New Delhi [India], June 4 (ANI): Centre through an affidavit on Friday informed the Delhi High Court that on May 12, 2021, the Drug Controller General of India (DCGI) has permitted Bharat Biotech to conduct clinical trials on healthy volunteers between 2 years to 18 years of age for its vacc